How McDonnell was paid
$12.8M in total for fiscal 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|
| Padraig McDonnellPresident; Chief Executive Officer | $1,141,345 | — | $8,169,850 | $2,017,759 | $1,436,809 | $61,473 | $12,827,236 |
| Rodney GonsalvesVice President; Controller; Principal Accounting Officer; Interim Chief Financial Officer | $513,559 | — | $1,687,786 | $175,921 | $291,638 | $26,883 | $2,695,787 |
| Simon MaySenior Vice President, Agilent President Life Sciences and Diagnostics Market Group | $635,385 | $500,000 | $1,801,424 | $444,959 | $472,395 | $17,406 | $3,871,569 |
| Angelica RiemannSenior Vice President, Agilent President Agilent Cross-Lab Group | $591,346 | — | $1,675,932 | $413,890 | $520,454 | $12,956 | $3,214,578 |
| Bret DiMarcoSenior Vice President, Chief Legal Officer | $679,808 | — | $1,990,228 | $491,517 | $475,466 | $21,574 | $3,658,593 |
| Robert McMahonFormer Senior Vice President; Former Chief Financial Officer | $665,000 | — | $4,000,968 | $827,780 | — | $44,583 | $5,538,331 |
What changed and why
- $12.8MCEO total compensation increased to $12,827,236 in fiscal year 2025 from $9,046,505 in fiscal year 2024.
- 86%Short-term cash incentive plan funding was achieved at 86% of target based on performance.
- 118%Long-term performance plan awards paid out at 118% for TSR and 64% for EPS programs.
- 89%Stockholders showed strong support with an 89% approval vote for the previous say-on-pay proposal.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.